PRASUN JALAL to Hepatitis C, Chronic
This is a "connection" page, showing publications PRASUN JALAL has written about Hepatitis C, Chronic.
Connection Strength
1.172
-
Hepatitis C infection and advanced hepatocellular carcinoma-To treat or not to treat? Cancer. 2022 10 01; 128(19):3441-3442.
Score: 0.613
-
Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2024 01; 22(1):72-80.e4.
Score: 0.163
-
International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients. J Viral Hepat. 2022 09; 29(9):807-816.
Score: 0.152
-
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2020 04; 18(4):974-983.
Score: 0.124
-
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. Gastroenterology. 2019 05; 156(6):1683-1692.e1.
Score: 0.120